ArticleOncotarget2017

BCL2L10 positive cells in bone marrow are an independent prognostic factor of azacitidine outcome in myelodysplastic syndrome and acute myeloid leukemia.

Valérie Vidal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.